No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Hold Rating
RAPT Therapeutics: Hold Rating Amid Strategic Uncertainties and Financial Resilience
RAPT Therapeutics Reprices Underwater Employee Stock Options
Here's Why We're A Bit Worried About RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
RAPT Therapeutics Reports Improved Q3 2024 Results
Stifel Maintains RAPT Therapeutics(RAPT.US) With Hold Rating, Maintains Target Price $2